BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET | BBIO Stock News

3 days ago

BridgeBio Pharma (BBIO, Financial) is set to release its Q1 2025 financial results on April 29, 2025.
A conference call will be held at 4:30 pm ET to discuss the earnings and program updates.
The webcast will be available for replay for 30 days on the company's website.

BridgeBio Pharma, Inc. (BBIO), a biopharmaceutical company specializing in genetic diseases, announced that it will release its first quarter 2025 financial results and program updates after the market closes on Tuesday, April 29, 2025. The company will host a conference call at 4:30 pm ET on the same day to discuss these results.

Investors and interested parties can access the live webcast of the earnings call through the "Events" page in the Investors section of BridgeBio's website. A registration link is also available online to join the live webcast. For those unable to attend the live session, a replay will be accessible for 30 days following the event.

BridgeBio Pharma continues to focus on its mission to discover, create, and introduce transformative medicines for patients suffering from genetic diseases. Since its founding in 2015, the company has developed a rich pipeline of projects, ranging from early-stage scientific research to advanced clinical trials.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.